Stem cell therapy for MS
Stem cell therapy may be able to positively impact Multiple Sclerosis patients. Mesenchymal stem cells have the ability to reduce inflammation and modulate the immune system, both of which may be extremely beneficial for MS patients.
Stem cell therapy, specifically the administration of mesenchymal stem cells (MSCs) for Multiple Sclerosis has demonstrated great potential to help improve symptoms and stabilize condition progression. The immunomodulatory (ability to regulate the immune system), tissue-protective and repair-promoting properties of MSCs demonstrated in multiple models make them an attractive therapy for Multiple Sclerosis (MS) and other conditions characterized by inflammation and/or tissue injury.
MS Patients may be able to expect an increase in energy, flexibility, strength, mobility, and control of basic function. Data is also beginning the show that mesenchymal stem cells (MSCs) administered intravenously may have the ability to halt disease progression for an extended period.
To read the entire article, please click on the link below: